Cargando…
Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study
Prior evidence indicates the potential central role of the acid sphingomyelinase (ASM)/ceramide system in the infection of cells with SARS-CoV-2. We conducted a multicenter retrospective observational study including 72,105 adult patients with laboratory-confirmed SARS-CoV-2 infection who were admit...
Autores principales: | Hoertel, Nicolas, Rezaei, Katayoun, Sánchez-Rico, Marina, Delgado-Álvarez, Alfonso, Kornhuber, Johannes, Gulbins, Erich, Olfson, Mark, Ouazana-Vedrines, Charles, Carpinteiro, Alexander, Cougoule, Céline, Becker, Katrin Anne, Alvarado, Jesús M., Limosin, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458150/ https://www.ncbi.nlm.nih.gov/pubmed/37631022 http://dx.doi.org/10.3390/ph16081107 |
Ejemplares similares
-
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms
por: Hoertel, Nicolas, et al.
Publicado: (2021) -
The acid sphingomyelinase/ceramide system in COVID-19
por: Kornhuber, Johannes, et al.
Publicado: (2021) -
Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatients
por: Hoertel, Nicolas, et al.
Publicado: (2021) -
Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells
por: Carpinteiro, Alexander, et al.
Publicado: (2021) -
Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, Nicolas, et al.
Publicado: (2022)